8 completed, 5 recruiting, 5 terminated, 5 withdrawn. 30 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 30 | Completed 8, Recruiting 5, Terminated 5, Withdrawn 5, Active not recruiting 4, Unknown 2, Suspended 1 |
| Phase 2 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
Follow Breast Carcinoma: new trials by email Literature Review of Breast Carcinoma trials Research Report on Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Trial of Preop Partial Radiation in Breast Cancer Patients Radiation: Accelerated Partial Breast Irradiation (APBI) - Early-stage Breast Cancer, Breast Carcinoma | Phase 1 | Suspended | Rutgers, The State University of New Jersey | 98 | 2025-09-02 | 2025-11-14 |
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations ATV-1601, ATV-1601 + Fulvestrant - Advanced Solid Tumors, Breast Cancer | Phase 1 | Active not recruiting | Atavistik Bio, Inc | 134 | 2025-07-29 | 2026-08-07 |
| Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer Biopsy, Biospecimen Collection, Bone Scan - Breast Carcinoma, Colorectal Carcinoma | Phase 1 | Recruiting | City of Hope Medical Center | 24 | 2025-05-27 | 2026-11-03 |
| TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamid, Fludarabine - Breast Cancer, Breast Carcinoma | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 85 | 2024-08-22 | 2024-11-12 |
| FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer Administration of CC-3 - Colorectal Cancer, Breast Carcinoma | Phase 1 | Recruiting | German Cancer Research Center | 89 | 2024-01-12 | 2025-05-21 |
| Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain | Phase 1 | Withdrawn | Northwestern University | 2023-12-31 | 2024-04-01 | |
| Vaccine Response With NT-I7 Recombinant human IL-7-hyFc (NT-I7), Vaccine sequence 1, Vaccine sequence 2 - Breast Carcinoma, Colorectal Adenocarcinoma | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2023-05-30 | 2023-11-02 | |
| Implantable Microdevice for TNBC - Pilot Study Implantable Microdevice (IMD) - Triple Negative Breast Cancer, Breast Cancer Stage II | Phase 1 | Withdrawn | Dana-Farber Cancer Institute | 2023-05-01 | 2023-05-18 | |
| Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC NUV-422, Fulvestrant - Advanced Breast Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | Withdrawn | Nuvation Bio Inc. | 2022-09-01 | 2023-07-11 | |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer | Phase 1 | Terminated | Nuvation Bio Inc. | 82 | 2022-03-29 | 2025-11-06 |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors NUV-422 - Glioma, Glioma, Malignant | Phase 1 | Terminated | Nuvation Bio Inc. | 74 | 2020-12-08 | 2023-07-14 |
| Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses Contrast-Enhanced Ultrasound, Perflutren Lipid Microspheres, Sulfur Hexafluoride Lipid Microspheres - Breast Carcinoma | Phase 1 | Recruiting | University of Southern California | 100 | 2020-11-05 | 2026-02-02 |
| Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study Biospecimen Collection, Genetic Counseling, Genetic Testing - Breast Carcinoma, Digestive System Neoplasm | Phase 1 | Completed | Mayo Clinic | 230 | 2020-06-29 | 2023-07-24 |
| Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus rVV-740CTA - Breast Carcinoma | Phase 1 | Withdrawn | University Hospital, Basel, Switzerland | 2020-03-01 | 2020-02-07 | |
| Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer Fingolimod, Fingolimod Hydrochloride, Questionnaire Administration - Breast Carcinoma | Phase 1 | Completed | Mayo Clinic | 2 | 2019-12-12 | 2023-07-21 |
| A Safety Study of SGN-CD47M in Patients With Solid Tumors SGN-CD47M - Soft Tissue Sarcoma, Colorectal Cancer | Phase 1 | Terminated | Seagen Inc. | 16 | 2019-07-17 | 2020-09-17 |
| 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer Gallium Ga 68-labeled GRPR Antagonist BAY86-7548, Magnetic Resonance Imaging, Positron Emission Tomography - Breast Carcinoma, Estrogen Receptor Positive | Phase 1 / Phase 2 | Completed | Andrei Iagaru | 5 | 2019-03-19 | 2023-12-13 |
| Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18 Fluorthanatrace - Breast Carcinoma, Fallopian Tube Carcinoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 300 | 2018-12-18 | 2026-10-06 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors XmAb20717 - Melanoma, Breast Carcinoma | Phase 1 | Completed | Xencor, Inc. | 150 | 2018-07-10 | 2022-12-01 |
Showing 20 of 30. Sign in to see all of them.
Breast Neoplasms (30) · Ovarian Neoplasms (9) · Colorectal Neoplasms (6) · Prostatic Neoplasms (6) · Triple Negative Breast Neoplasms (6) · Melanoma (5) · Sarcoma (5) · Endometrial Neoplasms (4) · Head and Neck Neoplasms (4) · Pancreatic Neoplasms (4) · Stomach Neoplasms (4) · Uterine Cervical Neoplasms (4) · Anus Neoplasms (3) · Brain Neoplasms (3) · Carcinoma, Hepatocellular (3)
Skin Diseases (30) · Skin and Connective Tissue Diseases (30) · Breast Diseases (29) · Neoplasms by Site (29) · Neoplasms (28) · Urogenital Diseases (14) · Digestive System Diseases (12) · Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Genital Diseases (12) · Urogenital Neoplasms (12) · Digestive System Neoplasms (11) · Male Urogenital Diseases (11) · Neoplasms by Histologic Type (11) · Endocrine Gland Neoplasms (10)
Magnetic Resonance Spectroscopy (5) · Fluorodeoxyglucose F18 (2) · Fulvestrant (2) · Interleukin-2 (2) · Radiation (2) · Specimen Handling (2) · veliparib (2) · 130-nm albumin-bound paclitaxel (1) · Adjuvants, Immunologic (1) · Albumin-Bound Paclitaxel (1) · BAY 86-7548 (1) · Biopsy (1) · Carboplatin (1) · Cyclophosphamide (1) · FAPI-46 (1)
National Cancer Institute (NCI) (3) · Nuvation Bio Inc. (3) · Mayo Clinic (2) · Andrei Iagaru (1) · Atavistik Bio, Inc (1) · City of Hope Medical Center (1) · Columbia University (1) · Dana-Farber Cancer Institute (1) · Dawn L. Hershman (1) · Essen Biotech (1) · German Cancer Research Center (1) · Jonsson Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1) · Mannkind Corporation (1) · Northwestern University (1)
United States (24) · China (3) · Australia (1) · France (1) · Germany (1) · Singapore (1) · Spain (1)
Ana Garrido-Castro, MD (1) · Andrei Iagaru (1) · Bino A Varghese, PhD (1) · Charles L Loprinzi (1) · Dawn Hershman, MD, MS (1) · Hussein A Tawbi (1) · Jeffrey Y Wong (1) · Jeremie Calais (1) · Kevin Kalinsky, MD, MS (1) · Lilie L Lin (1) · Michael Schmitt, MD, PhD (1) · Mustafa A Hyder, M.D. (1) · Niloy J Samadder (1) · Roger Stupp, MD (1)
PMID 16818691, PMID 18077538, PMID 34519839, PMID 34627593, PMID 36585452, PMID 38967722, PMID 39208372, PMID 40881578, PMID 42094867
P30CA047904 (2), U01CA062505 (2), U01CA099168 (2), U01CA168426 (2), UM1CA186690 (2), UM1CA186716 (2), UM1CA186717 (2), N01CM00100 (1), P30CA014089 (1), P30CA015083 (1), P30CA033572 (1), P30CA060553 (1), R01CA249329 (1), R01CA283603 (1), U01CA062490 (1)